Skip to Content

SEC Filings

Filing date	Form	Description	View
Jul 12, 2013	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001047469-13-007540.pdf 0001047469-13-007540.rtf 0001047469-13-007540.xls View HTML
Mar 07, 2024	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-24-062268.pdf 0001193125-24-062268.rtf 0001193125-24-062268.xls View HTML
Feb 13, 2013	5	Annual filing director officer or owner of more than ten percent.	0001179110-13-002570.pdf 0001179110-13-002570.rtf View HTML
Feb 13, 2013	5	Annual filing director officer or owner of more than ten percent.	0001179110-13-002572.pdf 0001179110-13-002572.rtf View HTML
Feb 13, 2013	5	Annual filing director officer or owner of more than ten percent.	0001179110-13-002573.pdf 0001179110-13-002573.rtf View HTML
Jan 27, 2012	8-A12B	Registration of certain classes of securities 12(b) of the Securities Exchange Act	0001104659-12-004686.pdf 0001104659-12-004686.rtf 0001104659-12-004686.xls View HTML
Dec 03, 2019	8-A12G	Registration of certain classes of securities 12(g) of the Securities Exchange Act	0001193125-19-304913.pdf 0001193125-19-304913.rtf 0001193125-19-304913.xls View HTML
Apr 10, 2012	8-K	Report of unscheduled material events or corporate event	0001104659-12-024491.pdf 0001104659-12-024491.rtf 0001104659-12-024491.xls View HTML
Apr 27, 2012	8-K	Report of unscheduled material events or corporate event	0001047469-12-004914.pdf 0001047469-12-004914.rtf 0001047469-12-004914.xls View HTML
May 15, 2012	8-K	Report of unscheduled material events or corporate event	0001104659-12-037122.pdf 0001104659-12-037122.rtf 0001104659-12-037122.xls View HTML

Data provided by Kaleidoscope.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2024 Merrimack Pharmaceuticals.